Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > The climb begins

<< Previous

Bullboard Posts

Next >>

Comment by GoldenHawkon Jun 26, 2018 2:20pm

110 Views

Post# 28231585

RE:RE:RE:RE:RE:RE:The climb begins

If the information they are releasing tomorrow at the meeting is really substantial then we could see a halt in the morning, news is shared at the meeting and sent out in a press release at the same time. I’m not saying this is going to happen but it could, hence the strong buying and I expect it to get better before close leading into tomorrow.